Device in FDA trial for patients with corneal opacity, high risk of penetrating keratoplasty complication
Ophthalmology Times, July 1 2019
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Ophthalmic innovation by the decades: The 2000s
2
EyePoint Pharmaceuticals details phase 3 program evaluating vorolanib intravitreal insert (DURAVYU) for DME
3
The Residency Report: Social media and the modern ophthalmologist
4
FDA approves Rayner’s RayOne EMV Toric intraocular lens
5
.png "Optometry Times"){kind=logo}
